| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |